In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith Un-audited Financial Results for the quarter ended 31st December, 2018 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the company in its meeting held today i.e. 11th February, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 12.00 P.M. and concluded at 3.20 P.M.

Pdf Link: Mangalam Drugs & Organics Ltd. - Results- Financial Results For December 31, 2018

Source : BSE - www.bseindia.com